Pfizer is testing an oral medicine to prevent Covid-19 after exposure. gettyKey FactsPfizer said it is launching a mid-to-late-stage clinical trial to test whether the antiviral drug, PF-07321332, can prevent Covid-19 infection in some 2,660 healthy adults living in the same house as someone with a confirmed symptomatic infection. TangentOral and nasal Covid-19 vaccines are also in the works. Further ReadingAntiviral pill: How close are we to a drug to treat Covid? (Financial Times)Pfizer’s New Oral Protease Inhibitor Could Possibly Treat And Prevent Covid-19 (Forbes)Oral Covid Vaccine Set To Begin Trials In Israel (Forbes)Full coverage and live updates on the Coronavirus

Source: Forbes September 27, 2021 16:07 UTC